← Leaderboards
Lisa Maves
Seattle Children'S Hospital
$2,405,915
Attributed
$3,768,884
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $571.1K · FY2009–25$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,768,884 · 4
By mechanism
R01$2,725,938 · 1
R03$552,980 · 2
R21$489,966 · 1
Top collaborators
- David Lee Mack5 shared
Most similar at Seattle Children'S Hospital
Same institution · by research overlap
- David Lee Mack$3,410,955
- Carol H Miao$27,105,989
Others in their field
Top investigators on “Zebrafish”
- Leonard I Zon · Children'S Hospital Boston$58,820,730
- Monte Westerfield · University Of Oregon$50,217,878
- Richard A Gibbs · Baylor College Of Medicine$49,965,365
- Karl Alexander Deisseroth · Stanford University$29,745,200
- William S Talbot · Stanford University$29,496,829
- Robert L Tanguay · Oregon State University$27,361,484
Research focus
ZebrafishGenesMuscleEmbryoMuscular DystrophiesMuscle FunctionDystrophinPhenotypeDuchenne Muscular DystrophyAffectTranscriptional RegulationEpigenetic ProcessScreeningLibrariesChromatin ModificationGene ExpressionMuscular StructureStandard Of CareMyocardiumPublic HealthFaceClinical TrialsAdrenal Cortex HormonesSkeletal Muscle
Grant awards (13)
Three-model platform for understanding DMD epigenetic mechanisms and advancing small molecule therapies$528,922
R01 · FY2025 · AR · contact PI
Three-model platform for understanding DMD epigenetic mechanisms and advancing small molecule therapies$528,922
R01 · FY2024 · AR · contact PI
Three-model platform for understanding DMD epigenetic mechanisms and advancing small molecule therapies$550,002
R01 · FY2023 · AR · contact PI
Three-model platform for understanding DMD epigenetic mechanisms and advancing small molecule therapies$571,121
R01 · FY2022 · AR · contact PI
Three-model platform for understanding DMD epigenetic mechanisms and advancing small molecule therapies$546,971
R01 · FY2021 · AR · contact PI
Using the dmd zebrafish animal model for identifying drug combination therapies and biomarkers$192,900
R21 · FY2016 · AR · contact PI
Regulation of muscle fiber type and resistance to muscular dystrophy$97,500
R03 · FY2016 · AR · contact PI
Using the dmd zebrafish animal model for identifying drug combination therapies and biomarkers$297,066
R21 · FY2015 · AR · contact PI
Regulation of muscle fiber type and resistance to muscular dystrophy$97,500
R03 · FY2015 · AR · contact PI
Regulation of muscle fiber type and resistance to muscular dystrophy$97,500
R03 · FY2014 · AR · contact PI
Pbx Homeodomain Proteins in Skeletal Muscle Differentiation$84,480
R03 · FY2011 · AR · contact PI
Pbx Homeodomain Proteins in Skeletal Muscle Differentiation$88,000
R03 · FY2010 · AR · contact PI
Pbx Homeodomain Proteins in Skeletal Muscle Differentiation$88,000
R03 · FY2009 · AR · contact PI